Mycamine (Astellas Pharma US, Inc.)


Welcome to the PulseAid listing for the Mycamine drug offered from Astellas Pharma US, Inc.. This Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Astellas Pharma US, Inc.
NON-PROPRIETARY NAME: Micafungin sodium
SUBSTANCE NAME: MICAFUNGIN SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-06-27
END MARKETING DATE: 0000-00-00


Mycamine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMycamine from Astellas Pharma US, Inc.
LABELER NAME: Astellas Pharma US, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 2006-06-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0469-3211_e337975a-4446-437a-b333-470c20e44f1a
PRODUCT NDC: 0469-3211
APPLICATION NUMBER: NDA021506

Other MICAFUNGIN SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Astellas Pharma US, Inc.Mycamine